Skip to main content
. 2019 Feb 20;19:38. doi: 10.1186/s12935-019-0756-7

Fig. 5.

Fig. 5

miR-96 activated AKT/GSK-3β/β-catenin signaling pathway through targeted inhibition of FOXO1. Detection of AKT and p-AKT protein (a), GSK-3 and p-GSK-3 protein (b), and β-catenin and p-β-catenin protein (c) by Western blot (d) by western blot in vivo. **P < 0.01